News for Sanofi (SNW.DE)

Waiving patent rights won’t be enough to launch massive vaccine campaigns in developing countries

GuruFocus Article or News written by insider and the topic is about:

GuruFocus Article or News written by GF Value and the topic is about:

Drugmakers and government labs are developing doses easier to take and transport to tackle coronavirus variants and avert future pandemics

Drugmakers and government labs are developing doses easier to take and transport to tackle coronavirus variants and avert future pandemics.

The European Medicines Agency will conduct an accelerated review of Eli Lilly and Co's rheumatoid arthritis drug Olumiant for hospitalized COVID-19 patients getting oxygen, the agency said on... | April 29, 2021

France stocks higher at close of trade; CAC 40 up 0.53%

GuruFocus Article or News written by insider and the topic is about:

The French drug maker intends to fill vials and finish packaging of as many as 200 million doses

The global tally of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 147 million on Monday, with India accounting for more than a...

Players in the microneedle drug delivery system market are leveraging growing demand for minimally invasive, pain-free therapeutic options for infectious and

The president said enough vaccines would be available two months earlier than he had previously indicated, after Merck agreed to help Johnson & Johnson produce shots.

By Sabrina Siddiqui and Tarini Parti Merck & Co. will help produce Johnson & Johnson's single-dose Covid-19 vaccine, President Biden plans to announce Tuesday, as the administration... | March 2, 2021

The president said enough vaccines would be available two months earlier than he had previously indicated, after Merck agreed to help Johnson & Johnson produce shots.

Generic injectable drugs are those which have same active ingredient as innovator drug and is equivalent to its innovator drug in dosage form, safety,

American Finance Trust Inc (NASDAQ:AFIN) is an undervalued, high-dividend REIT with a strong balance sheet and exceptional acquisition strategy.

Eli Lilly And Co (NYSE: LLY) announced a licensing deal Thursday with smaller biopharma Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) that helps Lilly ...

Bristol-Myers Squibb Co (NYSE: BMY) and Sanofi SA (NASDAQ: SNY) were ordered to pay the state of Hawaii more than $834 ...

U.S. stock futures rose Tuesday, adding to Friday's record closes for the Dow, S&P 500 and Nasdaq.